????? ?? ????? ?????? ????? ?????????? ??? ???. ???? ????????? ??????? ????.Where comparators and dosage regimens are referred to from the Summary Reports, they have already been picked through the HDAP for the purpose of carrying out the PMPRB's regulatory mandate, that's to assessment the prices of patented medicines offered in copyright to ensur